Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

This study was aimed at investigating the prevalence of H. pylori infection in liver disease patients and the relationship between vitamin D receptor gene variants and H. pylori infection and HCC risk in liver disease patients from Egypt.

Source: Discussion. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Case-control study.

Case-control study

Compares people with an outcome against people without it, examining exposures.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Three hundred patients who attended the Tropical Medicine department at Suez University Hospitals in Egypt participated in this case-control study.

Source: Methods.

The participants were divided into three groups: 100 healthy individuals who had no history of liver disease; 100 patients with chronic liver cirrhosis (LC) from hepatitis C; and 100 patients with cirrhosis from hepatitis C who had hepatocellular carcinoma (HCC).

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D receptor gene polymorphism and its association with the susceptibility to Helicobacter pylori infection in the Egyptian population with hepatocellular carcinoma

Case-control study · BMC Gastroenterology · 2026

Original publication title

Vitamin D receptor gene polymorphism and its association with the susceptibility to Helicobacter pylori infection in the Egyptian population with hepatocellular carcinoma

Asmaa Ibrahim; Shaymaa Abdelraheem Abdelhady; Fatma Rageh; Rasha Elgamal; Mohamed Medhat; Reham F. Othman; Hend A. Yassin; Yasmine N. Kamel; Eman M. Osman; Almaza Ali Salim; Samar S. Ahmed; Reham Mohamed Shaker; Doaa Eltaweel

© The Author(s) 2026

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

FokI and BsmI VDR polymorphisms may be linked to H. pylori infection and CagA strain susceptibility in patients with LC and HCC.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

This study aimed to estimate the frequency of H. pylori infection in patients with liver disorders, and identify the relationship between vitamin D receptor gene variants and susceptibility to H. pylori infections and HCC in Egyptian patients with liver diseases.

Source: Objective

Abstract: What methods does the paper describe?

This study consists of 300 adult patients classified into three groups: 100 healthy controls, 100 patients with liver cirrhosis, and 100 patients with HCC. Every patient was assessed for the presence of H. pylori by rapid test and polymerase chain reaction (PCR). Estimation of FokI and BsmI VDR gene polymorphism was performed by restriction fragment length polymorphism-Polymerase chain reaction (RFLP-PCR).

Source: Materials and methods

Abstract: Results

Infection with H. pylori was present in 46.7% of cases overall. Liver cirrhosis (LC) patients had a higher prevalence of H. pylori infection, followed by HCC patients (59% and 42%, respectively). Patients with LC and HCC were shown to be CagA positive, with the target CagA oncogene gene having an expected product size of 37.3% and 35.7%, respectively. LC and HCC patients showed a significant difference between the H. pylori-positive and: negative groups. Concerning the BsmI polymorphism, HCC patients with H. pylori-CagA positive had a higher GC genotype than those with H. pylori-CagA negative, and LC and HCC patients with H. pylori-CagA positive had a higher TT genotype than those with H. pylori-CagA negative.

Source: Results

Abstract: Conclusion

FokI and BsmI VDR polymorphisms may be linked to H. pylori infection and CagA strain susceptibility in patients with LC and HCC.

Source: Conclusion
Authors’ abstract

Objective

This study aimed to estimate the frequency of H. pylori infection in patients with liver disorders, and identify the relationship between vitamin D receptor gene variants and susceptibility to H. pylori infections and HCC in Egyptian patients with liver diseases.

Materials and methods

This study consists of 300 adult patients classified into three groups: 100 healthy controls, 100 patients with liver cirrhosis, and 100 patients with HCC. Every patient was assessed for the presence of H. pylori by rapid test and polymerase chain reaction (PCR). Estimation of FokI and BsmI VDR gene polymorphism was performed by restriction fragment length polymorphism-Polymerase chain reaction (RFLP-PCR).

Results

Infection with H. pylori was present in 46.7% of cases overall. Liver cirrhosis (LC) patients had a higher prevalence of H. pylori infection, followed by HCC patients (59% and 42%, respectively). Patients with LC and HCC were shown to be CagA positive, with the target CagA oncogene gene having an expected product size of 37.3% and 35.7%, respectively. LC and HCC patients showed a significant difference between the H. pylori-positive and: negative groups. Concerning the BsmI polymorphism, HCC patients with H. pylori-CagA positive had a higher GC genotype than those with H. pylori-CagA negative, and LC and HCC patients with H. pylori-CagA positive had a higher TT genotype than those with H. pylori-CagA negative.

Conclusion

FokI and BsmI VDR polymorphisms may be linked to H. pylori infection and CagA strain susceptibility in patients with LC and HCC.

Publication and source details

Original title: Vitamin D receptor gene polymorphism and its association with the susceptibility to Helicobacter pylori infection in the Egyptian population with hepatocellular carcinoma

Asmaa Ibrahim; Shaymaa Abdelraheem Abdelhady; Fatma Rageh; Rasha Elgamal; Mohamed Medhat; Reham F. Othman; Hend A. Yassin; Yasmine N. Kamel; Eman M. Osman; Almaza Ali Salim; Samar S. Ahmed; Reham Mohamed Shaker; Doaa Eltaweel

BMC Gastroenterology · 2026

© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.University of Sadat City

Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T16:30:07.583843+00:00

DOI: 10.1186/s12876-026-04740-6 · PMC13063462